546 related articles for article (PubMed ID: 29576597)
1. Anticoagulation Therapy for Venous Thromboembolism in the Real World - From the COMMAND VTE Registry.
Yamashita Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Konishi T; Akao M; Kobayashi Y; Inoue T; Oi M; Izumi T; Takahashi K; Tada T; Chen PM; Murata K; Tsuyuki Y; Sakai H; Saga S; Sasa T; Sakamoto J; Yamada C; Kinoshita M; Togi K; Ikeda T; Ishii K; Kaneda K; Mabuchi H; Otani H; Takabayashi K; Takahashi M; Shiomi H; Makiyama T; Ono K; Kimura T;
Circ J; 2018 Apr; 82(5):1262-1270. PubMed ID: 29576597
[TBL] [Abstract][Full Text] [Related]
2. Cancer-Associated Venous Thromboembolism in the Real World - From the COMMAND VTE Registry.
Sakamoto J; Yamashita Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Nishimoto Y; Sasa T; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Yoshikawa Y; Shiomi H; Kato T; Makiyama T; Ono K; Tamura T; Nakagawa Y; Kimura T;
Circ J; 2019 Oct; 83(11):2271-2281. PubMed ID: 31548438
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulation strategies and long-term recurrence in patients with venous thromboembolism in the era of direct oral anticoagulants.
Kaneda K; Yamashita Y; Morimoto T; Chatani R; Nishimoto Y; Ikeda N; Kobayashi Y; Ikeda S; Kim K; Inoko M; Takase T; Tsuji S; Oi M; Takada T; Otsui K; Kimura T;
Eur J Intern Med; 2023 Dec; 118():59-72. PubMed ID: 37574348
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors for Major Bleeding during Prolonged Anticoagulation Therapy in Patients with Venous Thromboembolism: From the COMMAND VTE Registry.
Kim K; Yamashita Y; Morimoto T; Kitai T; Yamane T; Ehara N; Kinoshita M; Kaji S; Amano H; Takase T; Hiramori S; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Shiomi H; Kato T; Makiyama T; Ono K; Furukawa Y; Kimura T;
Thromb Haemost; 2019 Sep; 119(9):1498-1507. PubMed ID: 31230344
[TBL] [Abstract][Full Text] [Related]
5. Transition of management strategies and long-term outcomes in cancer-associated venous thromboembolism from the warfarin era to the direct oral anticoagulant era.
Chatani R; Yamashita Y; Morimoto T; Kaneda K; Mushiake K; Kadota K; Nishimoto Y; Ikeda N; Kobayashi Y; Ikeda S; Kim K; Inoko M; Takase T; Tsuji S; Oi M; Kimura T;
Eur J Intern Med; 2024 May; 123():72-80. PubMed ID: 38278660
[TBL] [Abstract][Full Text] [Related]
6. Age and long-term outcomes of patients with venous thromboembolism: From the COMMAND VTE Registry.
Takahashi K; Yamashita Y; Morimoto T; Tada T; Sakamoto H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Chen PM; Murata K; Tsuyuki Y; Nishimoto Y; Sakamoto J; Togi K; Mabuchi H; Takabayashi K; Kato T; Ono K; Kimura T;
Int J Cardiol; 2023 Jul; 383():89-95. PubMed ID: 37156304
[TBL] [Abstract][Full Text] [Related]
7. Periprocedural management and clinical outcomes of invasive procedures after venous thromboembolism: from the COMMAND VTE registry.
Hata R; Yamashita Y; Morimoto T; Kadota K; Amano H; Murai R; Osakada K; Sano A; Takase T; Hiramori S; Kim K; Oi M; Akao M; Doi K; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Nishimoto Y; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Tsujisaka Y; Seko Y; Matsushita K; Yoneda F; Kato T; Ono K; Kimura T;
J Thromb Thrombolysis; 2022 Feb; 53(2):540-549. PubMed ID: 34524599
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors for Major Bleeding During Anticoagulation Therapy in Cancer-Associated Venous Thromboembolism - From the COMMAND VTE Registry.
Nishimoto Y; Yamashita Y; Kim K; Morimoto T; Saga S; Amano H; Takase T; Hiramori S; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Yoshikawa Y; Shiomi H; Kato T; Makiyama T; Ono K; Sato Y; Kimura T;
Circ J; 2020 Oct; 84(11):2006-2014. PubMed ID: 33012736
[TBL] [Abstract][Full Text] [Related]
9. Validation of the VTE-BLEED score's long-term performance for major bleeding in patients with venous thromboembolisms: From the COMMAND VTE registry.
Nishimoto Y; Yamashita Y; Morimoto T; Saga S; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Yoshikawa Y; Shiomi H; Kato T; Makiyama T; Ono K; Sato Y; Kimura T;
J Thromb Haemost; 2020 Mar; 18(3):624-632. PubMed ID: 31785073
[TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of strategies for restarting anticoagulation therapy after a first event of unprovoked venous thromboembolism.
Monahan M; Ensor J; Moore D; Fitzmaurice D; Jowett S
J Thromb Haemost; 2017 Aug; 15(8):1591-1600. PubMed ID: 28520199
[TBL] [Abstract][Full Text] [Related]
11. Risk of cancer after anticoagulation in patients with unprovoked venous thromboembolism: an observational cohort study.
Eischer L; Kammer M; Traby L; Kyrle PA; Eichinger S
J Thromb Haemost; 2017 Jul; 15(7):1368-1374. PubMed ID: 28407356
[TBL] [Abstract][Full Text] [Related]
12. [Optimal duration of anticoagulation of venous thromboembolism].
Savina EN; Couturaud F
J Mal Vasc; 2011 Dec; 36 Suppl 1():S28-32. PubMed ID: 22177766
[TBL] [Abstract][Full Text] [Related]
13. Sex Differences in Clinical Characteristics and Outcomes of Patients With Venous Thromboembolism - From the COMMAND VTE Registry.
Yoshikawa Y; Yamashita Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Shiomi H; Kato T; Makiyama T; Ono K; Kimura T;
Circ J; 2019 Jun; 83(7):1581-1589. PubMed ID: 31142685
[TBL] [Abstract][Full Text] [Related]
14. Optimal quality of vitamin K antagonist therapy in Japanese patients with venous thromboembolism.
Hiramori S; Yamashita Y; Morimoto T; Kadota K; Takase T; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Inoko M; Tada T; Izumi T; Chen PM; Murata K; Tsuyuki Y; Saga S; Nishimoto Y; Sasa T; Matsuda M; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Nakagawa Y; Kato T; Ono K; Ando K; Kimura T;
J Cardiol; 2022 Nov; 80(5):487-494. PubMed ID: 35882615
[TBL] [Abstract][Full Text] [Related]
15. Risk factors of thrombotic recurrence and major bleeding in patients with intermediate-risk for recurrence of venous thromboembolism.
Yamashita Y; Amano H; Morimoto T; Kadota K; Hata R; Matsushita K; Osakada K; Sano A; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Inoko M; Tada T; Chen PM; Murata K; Tsuyuki Y; Nishimoto Y; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Kato T; Ono K; Kimura T;
J Thromb Thrombolysis; 2022 Jan; 53(1):182-190. PubMed ID: 34228248
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism.
Lecumberri R; Alfonso A; Jiménez D; Fernández Capitán C; Prandoni P; Wells PS; Vidal G; Barillari G; Monreal M;
Thromb Haemost; 2013 Oct; 110(4):834-43. PubMed ID: 23846721
[TBL] [Abstract][Full Text] [Related]
17. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E
Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013
[TBL] [Abstract][Full Text] [Related]
18. Rivaroxaban for the treatment of venous thromboembolism. The SWIss Venous ThromboEmbolism Registry (SWIVTER).
Kucher N; Aujesky D; Beer JH; Mazzolai L; Baldi T; Banyai M; Hayoz D; Kaeslin T; Korte W; Escher R; Husmann M; Frauchiger B; Baumgartner I; Spirk D
Thromb Haemost; 2016 Aug; 116(3):472-9. PubMed ID: 27346301
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and Safety of Direct Oral Anticoagulants vs. Warfarin and Recurrence After Discontinuation in Patients With Acute Venous Thromboembolism in the Real World.
Hara N; Lee T; Nozato T; Terui Matsuyama M; Okata S; Nagase M; Mitsui K; Nitta G; Watanabe K; Miyazaki R; Nagamine S; Kaneko M; Nakamura T; Nagata Y; Miyamoto T; Obayashi T; Ashikaga T
Circ J; 2022 May; 86(6):923-933. PubMed ID: 34645732
[TBL] [Abstract][Full Text] [Related]
20. Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk.
Muriel A; Jiménez D; Aujesky D; Bertoletti L; Decousus H; Laporte S; Mismetti P; Muñoz FJ; Yusen R; Monreal M;
J Am Coll Cardiol; 2014 Apr; 63(16):1675-83. PubMed ID: 24576432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
